Back to search

Netherlands· NL-c6e6a20d011a

Terbinafine Aurobindo 125 mg, tabletten

A terbinafine product containing terbinafinehydrochloride, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC D01BA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTerbinafine Aurobindo 125 mg, tablett…ATCD01BA02REGISTER NO.NL-c6e6a20d011aPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Terbinafine is registered in 12 of 19 countries.

Countries holding a registration under ATC D01BA02 (terbinafine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Terbinafine · ATC D01BA02

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of terbinafine costs, country by country.

Normalised to the WHO defined daily dose (0.25 g), the median price runs from $1.38 in Italy to $3.55 in Switzerland — a ×2.6 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Terbinafine · price per daily dose (0.25 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.55
  • IT Italy$1.38
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TERBINAFINEHYDROCHLORIDE
Manufacturer
Aurobindo Pharma B.V.
Country
Netherlands (NL)
ATC code
D01BA02
ATC class
Terbinafine
Defined daily dose
0.25 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    106095

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

375 interactions on record for terbinafine.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Terbinafine · interactions on record

375 records

  • 16 severe
  • 128 moderate
  • 11 minor
  • 202 info

Most severe, free to view

  • EliglustatA16AX10severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe

18 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Terbinafine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terbinafine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Amykal, Lamisil
  • Belgium · Lamisil, Lamisil Dermgel
  • Bulgaria · Exoterbyn, Ербинол
  • Cyprus · Chemiderm, Chemiderm Τοπικό Αντιμυκnτιασικό Φάρμακο
  • Czechia · Lamisil, Terbinafin Actavis
  • Germany · Fungizid Extra, Lamisil
  • Denmark · Finigen, Lamisil
  • Estonia · Exotafin, Lamisil
  • Spain · Lamisil, Pevaryl Uñas
  • Finland · Fungorin, Lamisil
  • France · Fungster, Lamisil
  • United Kingdom (Northern Ireland) · Boots Athlete's Foot, Lamisil
  • Greece · Anaplas, Chemiderm
  • Croatia · Atere, Exoterbyn
  • Hungary · Exoterbyn, Lamisil Derma
  • Ireland · Fungasil, Lamisil
  • Iceland · Lamisil, Lamisil Once
  • Italy · Lamisil, Micutan
  • Lithuania · Lamisil, Lamisil Dermgel
  • Luxembourg · Lamisil, Lamisil Dermgel
  • Latvia · Exotafin, Lamisil
  • Malta · Fungasil, Fungasil 250mg Tablets
  • Norway · Lamisil, Lamisil Dermgel
  • Poland · Erfin, Lamisilatt
  • Portugal · Fungur, Lamisil
  • Romania · Exoterfyn, Fungisil Mk
  • Sweden · Azurifin, Lamisil
  • Slovenia · Exoter, Lamisil
  • Slovakia · Exoterin, Lamisil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/adad6f86-5146-4077-bfd6-377520b5c68c
GET /v1/drugs/adad6f86-5146-4077-bfd6-377520b5c68c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h106095_smpc.pdf",
  "strength": null,
  "atc_label": "Terbinafine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg106095",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE (E 464)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "TERBINAFINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h106095.pdf",
  "authorised_at": "2010/06/17",
  "procedure_number": "NL/H/2399/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "106095",
  "additional_monitoring": "N"
}

See everything about terbinafine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.